Ecuabaldra S.A.
IndustryHealth and pharmaceutical
Organisation typeCompany
Company Address
Alborada XII Etapa C.C. Gran Albocentro Of E-7,
090501, Guayaquil,
Guayas, Ecuador
Phone number00593987165565
Web page https://www.biotech-ec.com
Company Address kkuonqui@biotech-ec.com
Contact Person
Ms. Karina Kuonqui
Special Attorney
Phone00593987165565
Email kkuonqui@biotech-ec.com
OrganisationEco. Lassi Pensikkala
Project typeDistribution of hospital and medical technology, and instruments from Finland;
Joint venture
Project abstractEcuabaldra S.A., the Ecuadorian company specialised in import, sale and distribution of medical technology and instruments, is searching for Finnish manufacturers and distributors of medical equipment’s to import and distribute their products in Ecuador
Project descriptionEcuabaldra S.A. established in 2013 is based in Guayaquil, Ecuador and currently employs 5 persons.
The company operates in import, sale and distribution of medical and hospital supplies, technical support to hospital staff in the management of medical supplies, and sale of medical equipment. Ecuabaldra S.A. has a strong experience in the Ecuadorian market. It means for Finnish business partners following: Advantage in knowledge of the business environment within public and private hospitals in Ecuador, the company has a good credit credibility, trained personnel to manage medical business areas, established and operating since 2013, and good relationship with health control institution in Ecuador.
The customers so far have been hospital market throughout the Ecuador.
The company is currently looking for a partner in Finland to increase the number of products for the hospital market in the following lines: Neonatal cardiac surgery, Complementary lines to their current business, and General hospital services, technology and supplies.
Attachments
Number of employees5
Annual turnover in €0.5-2 million
Annual balance sheet total0.5-2 million
Certifications, standardsReg Mercantil Constitución Cía Ecuabaldra
Already engaged in international co-operationYes
Percentage of transnational activities10 to 49%